The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner. Meinhardt AL, Munkhbaatar E, Hockendorf U, Dietzen M, et al. Oncogene 2022 Jan 29. pii: 10.1038/s41388-021-02161.

Read + Share

Amedeo Smart

Independent Medical Education

Meinhardt AL, Munkhbaatar E, Hockendorf U, Dietzen M, et al. The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner. Oncogene 2022 Jan 29. pii: 10.1038/s41388-021-02161.
PMID: 35091677